NCT04840693View on ClinicalTrials.gov

Genomic and Metabolomic Markers Reflecting the Complications of Hypercortisolism (CUSHINGOMICS)

NARecruitingINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2026

Conditions
Adult Glucocorticoid ExcessAdult Adrenal Insufficiency
Interventions
BIOLOGICAL

Biological samples

blood, urine, saliva

OTHER

Complications

bone mineral density, diabetes, hypertension, quality of life (quality of life questionnaire SF-36)

Trial Locations (1)

75014

RECRUITING

Hôpital Cochin, Paris

All Listed Sponsors
collaborator

European Union's Horizon 2020 research and innovation programme under grant agreement No 633983

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER